**Question:** Sufentanyl is a potent opioid analgesic. What is its mechanism of action?

**Core Concept:** Sufentanyl is a synthetic opioid analgesic drug that belongs to the group of opioid agonists. It is a potent analgesic, meaning it has strong pain-relieving properties. Opioids exert their effects by binding to specific receptors in the central nervous system and peripheral tissues.

**Why the Correct Answer is Right:** Sufentanyl acts as a full agonist at the μ-opioid receptors. These receptors are primarily located in the central nervous system (CNS), particularly in the thalamus, hypothalamus, and brainstem. Activation of these receptors leads to the following key effects:

1. **Option A (μ-receptor):** Activation of μ-opioid receptors reduces the perception of pain, both centrally and peripherally. This is due to the modulation of the release of neurotransmitters, such as substance P, glutamate, and noradrenaline, which are involved in pain transmission and modulation.
2. **Option B (δ-receptor):** Sufentanyl has a very low affinity for δ-opioid receptors, explaining the minimal side effects typically associated with its use.
3. **Option C (κ-receptor):** Although sufentanyl can bind to κ-opioid receptors, its efficacy at these receptors is significantly lower than at μ-receptors. This helps to minimize unwanted side effects associated with κ-receptor activation, such as respiratory depression and constipation.
4. **Option D (non-specific receptor):** Sufentanyl's action is specific to μ-receptors, unlike non-specific opioids like morphine, which bind to multiple opioid receptors (μ, δ, and κ).

**Why Each Wrong Option is Incorrect:**

1. **Option A (δ-receptor):** Although sufentanyl can bind to δ-opioid receptors, its efficacy at these receptors is significantly lower than at μ-receptors. This makes δ-receptor activation less likely to occur with sufentanyl use compared to other opioids.
2. **Option B (κ-receptor):** As explained above, sufentanyl has a lower efficacy at κ-opioid receptors than at μ-receptors. This contributes to the minimal side effects associated with κ-receptor activation, making option B incorrect.
3. **Option C (non-specific receptor):** Unlike non-specific opioids like morphine, which bind to multiple opioid receptors (μ, δ, and κ), sufentanyl's action is specific to μ-receptors, making option C incorrect.
4. **Option D (non-opioid):** Sufentanyl is an opioid drug, acting as a μ-opioid receptor agonist. Therefore, option D is incorrect.

**Core Concept Summary:** Sufentanyl is a highly selective μ-opioid receptor agonist with minimal activation of other receptors (δ and κ). This selectivity contributes to its potent analgesic